Evaluation of Oxygen Delivery Through Nasal Cannula in Volunteers

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT02886312
Collaborator
(none)
30
1
12
2.5

Study Details

Study Description

Brief Summary

This study will evaluate patient comfort and oxygen delivery efficiency when providing supplemental oxygen through a nasal cannula to volunteers using an instrumented oxygen delivery system. The goals of the study are to evaluate different oxygen flow rates and oxygen delivery modes. In addition, the investigators will investigate if the system can detect apnea (cessation of breathing) and removal of the nasal cannula. The investigators will also investigate how well high flow oxygen delivered only during inspiration is tolerated and how much the end-tidal oxygen increases after two minutes of high oxygen flow delivered only during the inhalation phase of the breath.

Condition or Disease Intervention/Treatment Phase
  • Device: Supplemental Oxygen Delivery System
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Primary Purpose:
Supportive Care
Study Start Date :
Aug 1, 2015
Actual Primary Completion Date :
Aug 1, 2016
Actual Study Completion Date :
Aug 1, 2016

Outcome Measures

Primary Outcome Measures

  1. End-tidal Oxygen [Continuously throughout 30 minute volunteer study]

    Did the novel system increase end-tidal oxygen?

  2. Patient Comfort [Every 2 minutes up to 30 minutes]

    Did the patients feel it was more comfortable for a given end-tidal oxygen level?

  3. End-tidal Carbon Dioxide [Continuously throughout 30 minute volunteer study]

    Was end-tidal carbon dioxide measured more accurately using the novel system?

  4. Respiratory Rate [Continuously throughout 30 minute volunteer study]

    Compared respiratory rate against capnometry.

  5. Oxygen Saturation [Continuously throughout 30 minute volunteer study]

    Did the novel system increase oxygen saturation?

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy volunteers drawn from the general public and students, staff, and faculty of the University of Utah.
Exclusion Criteria:
  • Volunteers who self report respiratory diseases such as acute respiratory distress syndrome, pneumonia and lung cancer will be excluded. In addition, volunteers who self report respiratory conditions such as nasal or bronchial congestion due to a cold or allergies will be excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Utah Salt Lake City Utah United States 84112

Sponsors and Collaborators

  • University of Utah

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Joseph Orr, Ph.D., University of Utah
ClinicalTrials.gov Identifier:
NCT02886312
Other Study ID Numbers:
  • IRB_00083180
First Posted:
Sep 1, 2016
Last Update Posted:
Dec 14, 2017
Last Verified:
Dec 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes

Study Results

No Results Posted as of Dec 14, 2017